Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 46 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9839639

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  2. US 9840460

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  3. US 9834568

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  4. US 9833457

    Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  5. US 9828352

    Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR)

    The Regents of the University of California · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  6. US 9828373

    2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  7. US 9828367

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  8. US 9822068

    Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments

    The Regents of the University of California · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  9. US 9815796

    Pyrimidone carboxamide compounds as PDE2 inhibitors

    MSD R&D (China) Co. Ltd. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  10. US 9808458

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  11. US 9809541

    LSD1 inhibitors

    Mirati Therapeutics, Inc. · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  12. US 9809588

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  13. US 9808459

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  14. US 9801863

    Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis

    The Board of Regents of the University of Texas System · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  15. US 9802949

    Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  16. US 9803202

    Oligonucleotide-based inhibitors comprising locked nucleic acid motif

    MIRAGEN THERAPEUTICS, INC. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  17. US 9802904

    Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  18. US 9796671

    Aurora kinase inhibitors

    Regents of the University of Minnesota · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  19. US 9796664

    Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  20. US 9789095

    Inhibitors of calcium-activated chloride channels

    The Regents of the University of California · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  21. US 9790180

    Piperidine derivatives as HDAC1/2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  22. US 9783550

    Highly potent inhibitors of porcupine

    The Board of Regents of the University of Texas System · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  23. US 9783586

    Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  24. US 9783572

    Synthesis of syrbactin proteasome inhibitors

    The Regents of the University of California · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted